Vera Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Vera Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q4 2024.
  • Vera Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $5.49M, a 300% increase year-over-year.
  • Vera Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $15M, a 149% increase year-over-year.
  • Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $15M, a 149% increase from 2023.
  • Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $6.02M, a 226% increase from 2022.
  • Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.85M, a 3.01% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $15M $5.49M +$4.12M +300% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 $10.9M $3.17M +$1.52M +91.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.39M $3.64M +$1.83M +101% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.56M $2.73M +$1.54M +130% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $6.02M $1.37M +$231K +20.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 $5.79M $1.65M +$1.09M +192% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.71M $1.81M +$1.6M +786% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $3.1M $1.19M +$1.25M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.85M $1.14M +$1.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $444K $565K +$924K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$480K $204K -$2.21M -91.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.73M -$64K -$66K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.79M -$261K +$53K +16.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $1.74M -$359K +$64K +15.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.68M $2.41M +$2.84M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$1.17M $2K* +$5K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$1.17M -$314K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$423K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$431K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$3K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.